ENDRA Life Sciences (NDRA) Tops Q3 EPS by 3c

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.40), $0.03 better than the analyst estimate of ($0.43).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• American Express (AXP) Tops Q2 EPS by 13c
• American Express down 2% in premarket trade after Q2 revenue miss offsets EPS beat